US20150148692A1 - Chordal Sizer - Google Patents

Chordal Sizer Download PDF

Info

Publication number
US20150148692A1
US20150148692A1 US14/551,844 US201414551844A US2015148692A1 US 20150148692 A1 US20150148692 A1 US 20150148692A1 US 201414551844 A US201414551844 A US 201414551844A US 2015148692 A1 US2015148692 A1 US 2015148692A1
Authority
US
United States
Prior art keywords
sleeve
projection
projection member
distal
post
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
US14/551,844
Other versions
US10052096B2 (en
Inventor
Reed Quinn
Kellen Moulton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
On X Life Technologies Inc
Original Assignee
On X Life Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by On X Life Technologies Inc filed Critical On X Life Technologies Inc
Assigned to ON-X LIFE TECHNOLOGIES, INC. reassignment ON-X LIFE TECHNOLOGIES, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: QUINN, REED, MOULTON, KELLEN
Priority to US14/551,844 priority Critical patent/US10052096B2/en
Publication of US20150148692A1 publication Critical patent/US20150148692A1/en
Assigned to HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS AGENT reassignment HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS AGENT SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CRYOLIFE, INC., AS GRANTOR, ON-X LIFE TECHNOLOGIES, INC., AS GRANTOR, VALVE SPECIAL PURPOSE CO., LLC, AS GRANTOR
Assigned to ON-X LIFE TECHNOLOGIES, INC. reassignment ON-X LIFE TECHNOLOGIES, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: MEDEMA, RYAN
Assigned to ON-X LIFE TECHNOLOGIES, INC. (F/K/A MCRI, INC.), CARDIOGENESIS CORPORATION (N/K/A CRYOLIFE, INC.), HEMOSPHERE, INC., CRYOLIFE, INC., VALVE SPECIAL PURPOSE CO., LLC, CRYOLIFE ACQUISITION CORPORATION reassignment ON-X LIFE TECHNOLOGIES, INC. (F/K/A MCRI, INC.) RELEASE OF SECURITY INTEREST IN PATENTS Assignors: HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS ADMINISTRATIVE AGENT
Assigned to DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT reassignment DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT PATENT SECURITY AGREEMENT Assignors: CRYOLIFE, INC., ON-X LIFE TECHNOLOGIES, INC. (F/K/A MCRI, INC.)
Publication of US10052096B2 publication Critical patent/US10052096B2/en
Application granted granted Critical
Assigned to ARES CAPITAL CORPORATION reassignment ARES CAPITAL CORPORATION SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ON-X LIFE TECHNOLOGIES, INC.
Assigned to CRYOLIFE, INC., ON-X LIFE TECHNOLOGIES, INC. reassignment CRYOLIFE, INC. TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS Assignors: DEUTSCHE BANK AG NEW YORK BRANCH
Active legal-status Critical Current
Adjusted expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/103Detecting, measuring or recording devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
    • A61B5/107Measuring physical dimensions, e.g. size of the entire body or parts thereof
    • A61B5/1076Measuring physical dimensions, e.g. size of the entire body or parts thereof for measuring dimensions inside body cavities, e.g. using catheters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0469Suturing instruments for use in minimally invasive surgery, e.g. endoscopic surgery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/02007Evaluating blood vessel condition, e.g. elasticity, compliance
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/00234Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
    • A61B2017/00238Type of minimally invasive operation
    • A61B2017/00243Type of minimally invasive operation cardiac
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0469Suturing instruments for use in minimally invasive surgery, e.g. endoscopic surgery
    • A61B2017/0474Knot pushers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/06Measuring instruments not otherwise provided for
    • A61B2090/061Measuring instruments not otherwise provided for for measuring dimensions, e.g. length
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2442Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
    • A61F2/2454Means for preventing inversion of the valve leaflets, e.g. chordae tendineae prostheses
    • A61F2/2457Chordae tendineae prostheses

Definitions

  • heart valve replacement is a well-known procedure in which an artificial heart valve prosthesis is implanted in place of a diseased or malfunctioning heart valve.
  • Heart valve prostheses may be mechanical or bioprosthetic. Use of mechanical valves typically requires extensive anticoagulation therapy. The need for anticoagulation therapy can be avoided in general by the use of artificial biological heart valves, such as bovine xenografts. Nevertheless, dystrophic calcification with subsequent degeneration is a cause of failure of such bioprostheses in the long term. When mitral or tricuspid valve replacement is performed, the chordae tendineae are cut, thus leaving the geometry and function of the ventricle impaired and in need of reconstruction.
  • chordae As an alternative to conventional heart valve replacement operations, diseased and malfunctioning chordae can be repaired by surgically replacing diseased heart chordae with artificial chordae.
  • One known way of replacing a malfunctioning chordae uses a simple suture with a needle on each end of the suture. The suture is stitched through the papillary muscle and secured thereto with a knot. The two ends of the suture are then similarly stitched through the free ends of the valve leaflets. The valve will not function properly if the length of the artificial chordae between the papillary muscle and valve leaflet is overly long or overly short. Replacement chords are discussed more specifically in, for example, U.S. patent application Ser. Nos. 12/750,800 and 12/238,322.
  • FIG. 1 includes a perspective view of an embodiment of the invention.
  • FIG. 2 includes a side cross-sectional view of an embodiment of the invention.
  • FIG. 3 includes a perspective view of “hooks” in an embodiment of the invention.
  • FIG. 4 includes a perspective view of rotated hooks in an embodiment of the invention.
  • FIG. 5 includes a perspective view of hooks coupled to cardiac tissue in an embodiment of the invention.
  • FIG. 6 includes a perspective view of offset hooks in an embodiment of the invention.
  • FIG. 7 includes a side view of an embodiment of the invention.
  • Coupled may indicate elements are in direct physical or electrical contact with each other and “coupled” may indicate elements co-operate or interact with each other, but they may or may not be in direct physical or electrical contact.
  • An embodiment helps a healthcare provider better determine the correct chord size for valve repair related chord replacement.
  • An embodiment provides features that allow the surgeon to more easily tie the correct size of loop for chord replacement.
  • An embodiment includes a chordal sizer that is a single-use medical device that assists the surgeon in determining the correct size of a chordae tendineae prosthetic loop (or functional equivalent thereof) to implant in mitral valve repair surgery. Once the loop size is determined, the chordal sizer can also be used as an instrument to quickly tie loops of the correct size, or it indicates to the surgeon which size of pre-configured loops prosthesis to select.
  • FIG. 1 includes a perspective view of an embodiment of the invention.
  • System 100 includes projections 102 , 103 (see also FIG. 3 ) at, in an undeployed state, a distal end portion of barrel or sleeve 101 .
  • Barrel 101 may be rotated by rotating dial or handling portion 104 , thereby not only rotating barrel 101 but also rotating projection 103 .
  • projection 102 may be rotated between 0 and 360 degrees from projection 103 .
  • FIG. 4 shows a rotation of about 90 degrees whereas FIG. 3 shows a rotation of about 0 degrees.
  • rotating dial 104 may only rotate one of projections 102 , 103 without necessarily rotating barrel 101 .
  • An embodiment may rotate projection 102 and not projection 103 with or without rotating barrel 101 .
  • Projection 102 may deploy from barrel 101 (via deployment of shaft, rod, or post 115 in FIG. 2 ) and away from projection 103 by advancing lever 105 (and shaft 115 ) distally and projection 102 may retreat towards barrel 101 and towards projection 103 by withdrawing level 105 (and shaft 115 ) proximally.
  • barrel 101 does not rotate but instead shaft 115 rotates to thereby rotate projection 102 and/or projection 103 .
  • both projections 102 , 103 may rotate.
  • the amount of deployment of projection 102 from projection 103 is indicated by viewing through window 106 at scale 109 , which includes indicators (e.g., changes in color, raised notches or projections) 109 ′, 109 ′′ (see FIG. 2 ) that translate into a length of desired artificial chord.
  • scale 109 is printed on a label and coupled to shuttle 105 via coupling member 116 .
  • Scale 109 may have color-coded regions that correspond with the label colors for pre-measured loops products.
  • a measurement in the “blue” area of scale 109 may indicate the need to use pre-sized chord A but a measurement in the yellow area of scale 109 may indicate the need to use pre-sized chord B.
  • Pre-sized chords A and B may be included in a package delivered to the hospital from which the doctor may select the proper length of chord after measuring the patient's anatomy. Not all embodiments include a scale.
  • An embodiment is made with injection molded plastics. Silicone O-rings provide friction internal to the device. Specifically, O-rings 107 , 108 ( FIG. 2 ) may help provide some element of resistance towards deployment of projection 102 from projection 103 and/or rotation of projection 102 with respect to projection 103 .
  • one O-ring 107 fits around the back of barrel 101 . This O-ring provides compression to hold the barrel flush against the housing pieces. It allows the barrel to rotate (i.e., to rotate the leaflet hook 103 in relation to the papillary pointer 102 ) when enough force is provided to overcome the friction.
  • the other two O-rings 108 are adjacent each other and fit around the shaft 115 . These two O-rings are held in place by features in the housing.
  • the shaft 115 can be advanced by sliding shuttle 105 .
  • the two O-rings 108 on the shaft 115 provide friction to prevent the shaft 115 from moving unintentionally.
  • O-rings 107 , 108 may reside in grooves (not shown) in shaft 115 so the O-rings are unstressed during shipping and storage and will not relax.
  • projection 103 may be considered a form of hook or cradle with which to retain or support leaflet 113 .
  • Projection 103 hooks/stabilizes mitral valve leaflet 113 , allowing the surgeon to manipulate leaflet 113 into a desired position.
  • Projection 102 serves as a “papillary pointer” that extends and points toward the papillary muscle.
  • Location 114 indicates the planned site of desired papillary muscle attachment.
  • projections 102 , 103 are orthogonal to one another (or at least not in-line with each other) when leaflet 113 is hooked or restrained (see FIG. 4 ).
  • projection 103 This orientation allows the surgeon to more clearly see where the papillary pointer is pointing considering projection 103 will now no longer block a view of projection 102 and the papillary muscle.
  • the papillary pointer 102 does not hook onto any part of the heart in an embodiment.
  • a portion (see element 114 of FIG. 5 ) of projection 102 simply points to the location on the papillary muscle where the surgeon would like to implant the prosthetic chords to determine the proper length of the chord(s).
  • the health care provider e.g., surgeon
  • hook is not mean to include a piecing object but more to include a retention member used to retain, support, or stabilize tissue, such as a heart valve leaflet.
  • FIG. 6 includes an embodiment that accounts for potential measurement errors.
  • projections 202 , 203 are each a few millimeters wide (see distances 231 and 233 )
  • a loop tied around the projections may be larger than the distance between the portions of the projections that indicate exactly where the physician desires loop placement.
  • the papillary pointer feature 202 is offset several millimeters (distance 232 ) from where the suture is tied at location 234 .
  • this offset may be to varying degrees.
  • the offset shown in FIG. 6 as distance 232
  • the offset may directly equal the sum of the widths or areas of thickness (both shown in FIG. 6 as distances 231 , 233 ), may be slightly less or more than this sum, and the like.
  • the measuring features 102 , 103 at the distal end portion of system 100 may be separated from the loop tying features. Separate loop tying features could possibly be placed further back on the device.
  • FIG. 7 This embodiment shows how the doctor could use posts 302 , 303 to measure the proposed chord length and then use posts 304 , 305 for tying the proper length of chord.
  • Posts 304 , 305 could be much larger than posts 302 , 303 since they are not placed in the patient (unlike posts 302 , 303 ) and these larger posts may facilitate knot tying and the like.
  • the distance 335 between posts 302 , 303 is equal to the distance 336 between posts 304 , 305 . This equality of distances is seen in both the deployed and undeployed positions (e.g., distance 331 equals distance 332 in an undeployed state and distance 335 equals distance 336 in a deployed state).
  • An embodiment includes a method for determining proper chord length.
  • the method may use an embodiment such as the embodiment of FIG. 1 , which assists the surgeon in determining the proper length of chordal replacement prostheses needed to repair the mitral valve. It may be used to help the surgeon select a preconfigured prosthesis, or to easily configure the correct size using straight suture material, during mitral valve repair.
  • the physician first uses leaflet hook 103 to support the edge of the leaflet 113 in the desired position.
  • the physician then uses thumb-slide 105 to extend the papillary hook 102 to the planned site 114 of attachment to the papillary muscle 112 as shown in FIG. 5 .
  • the slide 105 may lock automatically when the physician no longer pushes or pulls upon it.
  • the leaflet hook 103 may be rotated to any desired angle relative to the papillary hook 102 to improve visibility while the papillary pointer 102 points to the desired attachment site 114 .
  • the physician rotates the leaflet hook 103 by using the grips 104 at the base of the barrel 101 .
  • the colors/projections 109 , 109 ′′ of scale 109 match the label colors for corresponding pre-measured loops prostheses with a variety of sizes being made available in a kit.
  • the scale indicator e.g., a number or color or projection
  • the physician rotates the barrel 101 so that the leaflet hook 103 is again aligned with the papillary hook 102 (after having been rotated away from papillary hook during measuring) prior to tying loops around projections 102 , 103 .
  • the physician can rotate hooks 102 , 103 with regard to one another to achieve better site visibility without affecting the measured length.
  • a saline test may be performed to verify that the chordal loop size is correct and that the valve is competent.
  • One or more embodiments provide several advantages such as, without limitation: (1) offset of the papillary pointer 202 , 203 and the feature that suture is tied around (see, e.g., FIG. 6 ), (2) rotating leaflet hook (e.g., FIG. 4 ), (3) color-coded scale (e.g., element 109 ), (4) using O-rings 108 , 109 for friction to stabilize projection deployment and placement, and (5) tying the sutures using posts that are proximal to the papillary pointing element (e.g., FIG. 7 ).
  • Various embodiments include only a selected one of (1)-(5) while other embodiments include some or all of (1)-(5).
  • embodiments recognize a previously underappreciated problem regarding the visualization of papillary muscle while retaining a leaflet and provides a solution that provides better visualization while retaining accurate chord length measurement.
  • scale 109 was indicated as a good way to measure the length of desired cords based on distances between projections 102 , 103
  • a physician may use an image (e.g., echocardiogram) to determine a length and then “dial” in that length using scale 109 .
  • image e.g., echocardiogram
  • the loops can be quickly tied using projections 102 , 103 .
  • the scale 109 may be unnecessary. However, using scale 109 in such a situation would allow the physician to quickly reset the hooks 102 , 103 if for whatever reason the hooks were moved from their proper separation from one another.
  • the hooks 102 , 103 rotate in 90 degree intervals whereby one of the hooks “clicks” into place at 90 degree intervals based on notches and spring member systems used to retain a member within a notch until the member is forcibly removed from the notch in order to rotate hooks 102 , 103 about each other.
  • the two projections 102 , 103 may be permanently offset with each other (i.e., a line connect the two points is not collinear or parallel to a long axis of the device).
  • a third projection may be included such that first projection is located where element 102 is in FIG. 3 , a second projection is located where element 103 is located in FIG. 3 , and simultaneously a third projection is located where element 103 is located in FIG. 4 .
  • the device may be simplified by removing the rotation element and providing “two static versions” of element 103 , one to measure (i.e., the rotated version) and another for tying.
  • a third projection may be included such that a first projection is located where element 103 is in FIG. 3 , a second projection is located where element 102 is located in FIG. 3 , and simultaneously a third projection is located where element 102 is located in FIG. 4 .
  • the device may be simplified by removing the rotation element and providing “two static versions” of element 102 , one to measure (i.e., the rotated version) and another for tying.
  • the embodiment may provide the two static versions of element 102 are co-planar with each other and one of the two static versions of element 102 and element 103 are co-planar with each other. These two planes may be orthogonal to each other in an embodiment but not necessarily so in other embodiments.
  • VSD Ventricular Septal Defect
  • An embodiment includes a cardiovascular surgical apparatus comprising: a sleeve including a distal sleeve end, a proximal sleeve end, and a sleeve long axis (e.g., axis 190 of FIG. 3 , which is orthogonal to sleeve short axis 191 ) extending from the distal sleeve end to the proximal sleeve end.
  • a sleeve including a distal sleeve end, a proximal sleeve end, and a sleeve long axis (e.g., axis 190 of FIG. 3 , which is orthogonal to sleeve short axis 191 ) extending from the distal sleeve end to the proximal sleeve end.
  • the sleeve may be a conduit but is not so limited and may include, for example only, a member with a channel included therein.
  • a gutter for a house or a bowling alley lane may include a “sleeve” which could function as a channel for rod 115 .
  • a “long axis” as used herein is the longest of the main axes for an object and is an imaginary line passing longitudinally through the center of a body.
  • the body further includes a post (e.g., rod) including a distal post end and a proximal post end; a first projection member, coupled to the distal sleeve end, including a first projection member main body (e.g., element 195 ) and a first projection member retention body (e.g., element 194 ); and a second projection member coupled to the proximal sleeve end.
  • a post e.g., rod
  • first projection member coupled to the distal sleeve end, including a first projection member main body (e.g., element 195 ) and a first projection member retention body (e.g., element 194 ); and a second projection member coupled to the proximal sleeve end.
  • the first and second projection members both project outwards and away from the sleeve long axis;
  • the post telescopes distally from within the sleeve and away from the distal sleeve end;
  • at least one of the first and second projection members rotates at least 45 degrees about the sleeve long axis and with respect to another of the first and second projection members;
  • the first projection member retention body includes a long axis (e.g., axis 193 ) generally parallel to the sleeve long axis.
  • the first projection member main body includes a long axis (e.g., axis 192 ) generally orthogonal to the sleeve long axis (e.g., axis 190 ).
  • At least one of the first and second projection members rotates at least 15, 25, 35, 45, 55, 65, 75, 85, 90, 100, 110, 120, 130, 140, 150, 160, 170, 180 degrees or more about the sleeve long axis and with respect to another of the first and second projection members.
  • projections 103 , 103 include “L” shaped members
  • other projections in other embodiments may not necessarily include “L” shaped members but may instead include a sphere or ball affixed to a post that projects away from axis 190 (orthogonally or otherwise).
  • Projection 102 , 103 include portions that project away from axis 190 . They may do so at 90 degree angles (see FIG. 3 ) or otherwise such as 30, 45, 60, 110, 130, 145, 160, 180 degrees and the like.
  • projection 103 may include an “L” member while projection 102 is merely a pointer with which to point at muscle tissue but not necessarily configured to retain or support tissue.

Abstract

An embodiment includes a cardiovascular surgical apparatus comprising: a sleeve including a distal sleeve end, a proximal sleeve end, and a sleeve long axis extending from the distal sleeve end to the proximal sleeve end; a post including a distal post end and a proximal post end; a first projection member, coupled to the distal sleeve end, including a first projection member main body and a first projection member retention body; a second projection member coupled to the proximal sleeve end; wherein (a) the post telescopes distally from within the sleeve and away from the distal sleeve end; (b) at least one of the first and second projection members rotates at least 45 degrees with respect to another of the first and second projection members; and (c) the first projection member retention body includes a long axis generally parallel to the sleeve long axis. Other embodiments are described herein.

Description

    PRIORITY CLAIM
  • This application claims priority to United States Provisional Patent Application No. 61/907,904 filed on Nov. 22, 2013 and entitled “Chordal Sizer”, the content of which is hereby incorporated by reference.
  • BACKGROUND
  • As addressed in U.S. patent application Ser. No. 12/750,800, heart valve replacement is a well-known procedure in which an artificial heart valve prosthesis is implanted in place of a diseased or malfunctioning heart valve. Heart valve prostheses may be mechanical or bioprosthetic. Use of mechanical valves typically requires extensive anticoagulation therapy. The need for anticoagulation therapy can be avoided in general by the use of artificial biological heart valves, such as bovine xenografts. Nevertheless, dystrophic calcification with subsequent degeneration is a cause of failure of such bioprostheses in the long term. When mitral or tricuspid valve replacement is performed, the chordae tendineae are cut, thus leaving the geometry and function of the ventricle impaired and in need of reconstruction.
  • As an alternative to conventional heart valve replacement operations, diseased and malfunctioning chordae can be repaired by surgically replacing diseased heart chordae with artificial chordae. One known way of replacing a malfunctioning chordae uses a simple suture with a needle on each end of the suture. The suture is stitched through the papillary muscle and secured thereto with a knot. The two ends of the suture are then similarly stitched through the free ends of the valve leaflets. The valve will not function properly if the length of the artificial chordae between the papillary muscle and valve leaflet is overly long or overly short. Replacement chords are discussed more specifically in, for example, U.S. patent application Ser. Nos. 12/750,800 and 12/238,322.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • Features and advantages of embodiments of the present invention will become apparent from the appended claims, the following detailed description of one or more example embodiments, and the corresponding figures. Where considered appropriate, reference labels have been repeated among the figures to indicate corresponding or analogous elements.
  • FIG. 1 includes a perspective view of an embodiment of the invention.
  • FIG. 2 includes a side cross-sectional view of an embodiment of the invention.
  • FIG. 3 includes a perspective view of “hooks” in an embodiment of the invention.
  • FIG. 4 includes a perspective view of rotated hooks in an embodiment of the invention.
  • FIG. 5 includes a perspective view of hooks coupled to cardiac tissue in an embodiment of the invention.
  • FIG. 6 includes a perspective view of offset hooks in an embodiment of the invention.
  • FIG. 7 includes a side view of an embodiment of the invention.
  • DETAILED DESCRIPTION
  • Reference will now be made to the drawings wherein like structures may be provided with like suffix reference designations. In order to show the structures of various embodiments more clearly, the drawings included herein are diagrammatic representations of devices and may only show the structures useful to understand the illustrated embodiments. Additional structures known in the art may not have been included to maintain the clarity of the drawings. “An embodiment”, “various embodiments” and the like indicate embodiment(s) so described may include particular features, structures, or characteristics, but not every embodiment necessarily includes the particular features, structures, or characteristics. Some embodiments may have some, all, or none of the features described for other embodiments. “First”, “second”, “third” and the like describe a common object and indicate different instances of like objects are being referred to. Such adjectives do not imply objects so described must be in a given sequence, either temporally, spatially, in ranking, or in any other manner. “Connected” may indicate elements are in direct physical or electrical contact with each other and “coupled” may indicate elements co-operate or interact with each other, but they may or may not be in direct physical or electrical contact.
  • An embodiment helps a healthcare provider better determine the correct chord size for valve repair related chord replacement. An embodiment provides features that allow the surgeon to more easily tie the correct size of loop for chord replacement. An embodiment includes a chordal sizer that is a single-use medical device that assists the surgeon in determining the correct size of a chordae tendineae prosthetic loop (or functional equivalent thereof) to implant in mitral valve repair surgery. Once the loop size is determined, the chordal sizer can also be used as an instrument to quickly tie loops of the correct size, or it indicates to the surgeon which size of pre-configured loops prosthesis to select.
  • FIG. 1 includes a perspective view of an embodiment of the invention. System 100 includes projections 102, 103 (see also FIG. 3) at, in an undeployed state, a distal end portion of barrel or sleeve 101. Barrel 101 may be rotated by rotating dial or handling portion 104, thereby not only rotating barrel 101 but also rotating projection 103. As a result, projection 102 may be rotated between 0 and 360 degrees from projection 103. FIG. 4 shows a rotation of about 90 degrees whereas FIG. 3 shows a rotation of about 0 degrees. In an embodiment rotating dial 104 may only rotate one of projections 102, 103 without necessarily rotating barrel 101. An embodiment may rotate projection 102 and not projection 103 with or without rotating barrel 101. Projection 102 may deploy from barrel 101 (via deployment of shaft, rod, or post 115 in FIG. 2) and away from projection 103 by advancing lever 105 (and shaft 115) distally and projection 102 may retreat towards barrel 101 and towards projection 103 by withdrawing level 105 (and shaft 115) proximally. In an embodiment barrel 101 does not rotate but instead shaft 115 rotates to thereby rotate projection 102 and/or projection 103. In an embodiment both projections 102, 103 may rotate.
  • In an embodiment, the amount of deployment of projection 102 from projection 103 is indicated by viewing through window 106 at scale 109, which includes indicators (e.g., changes in color, raised notches or projections) 109′, 109″ (see FIG. 2) that translate into a length of desired artificial chord. For example, scale 109 is printed on a label and coupled to shuttle 105 via coupling member 116. Scale 109 may have color-coded regions that correspond with the label colors for pre-measured loops products. Thus a measurement in the “blue” area of scale 109 may indicate the need to use pre-sized chord A but a measurement in the yellow area of scale 109 may indicate the need to use pre-sized chord B. Pre-sized chords A and B may be included in a package delivered to the hospital from which the doctor may select the proper length of chord after measuring the patient's anatomy. Not all embodiments include a scale.
  • An embodiment is made with injection molded plastics. Silicone O-rings provide friction internal to the device. Specifically, O-rings 107, 108 (FIG. 2) may help provide some element of resistance towards deployment of projection 102 from projection 103 and/or rotation of projection 102 with respect to projection 103. In an embodiment one O-ring 107 fits around the back of barrel 101. This O-ring provides compression to hold the barrel flush against the housing pieces. It allows the barrel to rotate (i.e., to rotate the leaflet hook 103 in relation to the papillary pointer 102) when enough force is provided to overcome the friction. The other two O-rings 108 are adjacent each other and fit around the shaft 115. These two O-rings are held in place by features in the housing. The shaft 115 can be advanced by sliding shuttle 105. The two O-rings 108 on the shaft 115 provide friction to prevent the shaft 115 from moving unintentionally. O- rings 107, 108 may reside in grooves (not shown) in shaft 115 so the O-rings are unstressed during shipping and storage and will not relax.
  • As seen in FIG. 5, in an embodiment projection 103 may be considered a form of hook or cradle with which to retain or support leaflet 113. Projection 103 hooks/stabilizes mitral valve leaflet 113, allowing the surgeon to manipulate leaflet 113 into a desired position. Projection 102 serves as a “papillary pointer” that extends and points toward the papillary muscle. Location 114 indicates the planned site of desired papillary muscle attachment. In an embodiment projections 102, 103 are orthogonal to one another (or at least not in-line with each other) when leaflet 113 is hooked or restrained (see FIG. 4). This orientation allows the surgeon to more clearly see where the papillary pointer is pointing considering projection 103 will now no longer block a view of projection 102 and the papillary muscle. The papillary pointer 102 does not hook onto any part of the heart in an embodiment. A portion (see element 114 of FIG. 5) of projection 102 simply points to the location on the papillary muscle where the surgeon would like to implant the prosthetic chords to determine the proper length of the chord(s).
  • In an embodiment, the health care provider (e.g., surgeon) can tie suture loops directly around the papillary pointer 102 and the leaflet hook 103. As used herein, “hook” is not mean to include a piecing object but more to include a retention member used to retain, support, or stabilize tissue, such as a heart valve leaflet.
  • FIG. 6 includes an embodiment that accounts for potential measurement errors. For example, because projections 202, 203 are each a few millimeters wide (see distances 231 and 233), a loop tied around the projections may be larger than the distance between the portions of the projections that indicate exactly where the physician desires loop placement. To correct for this, the papillary pointer feature 202 is offset several millimeters (distance 232) from where the suture is tied at location 234. Regarding this offset, this offset may be to varying degrees. For example, the offset (shown in FIG. 6 as distance 232) may directly equal the sum of the widths or areas of thickness (both shown in FIG. 6 as distances 231, 233), may be slightly less or more than this sum, and the like.
  • In an embodiment the measuring features 102, 103 at the distal end portion of system 100 may be separated from the loop tying features. Separate loop tying features could possibly be placed further back on the device. For example, see FIG. 7. This embodiment shows how the doctor could use posts 302, 303 to measure the proposed chord length and then use posts 304, 305 for tying the proper length of chord. Posts 304, 305 could be much larger than posts 302, 303 since they are not placed in the patient (unlike posts 302, 303) and these larger posts may facilitate knot tying and the like. The distance 335 between posts 302, 303 is equal to the distance 336 between posts 304, 305. This equality of distances is seen in both the deployed and undeployed positions (e.g., distance 331 equals distance 332 in an undeployed state and distance 335 equals distance 336 in a deployed state).
  • An embodiment includes a method for determining proper chord length. The method may use an embodiment such as the embodiment of FIG. 1, which assists the surgeon in determining the proper length of chordal replacement prostheses needed to repair the mitral valve. It may be used to help the surgeon select a preconfigured prosthesis, or to easily configure the correct size using straight suture material, during mitral valve repair.
  • In the method the physician first uses leaflet hook 103 to support the edge of the leaflet 113 in the desired position. The physician then uses thumb-slide 105 to extend the papillary hook 102 to the planned site 114 of attachment to the papillary muscle 112 as shown in FIG. 5. The slide 105 may lock automatically when the physician no longer pushes or pulls upon it. The leaflet hook 103 may be rotated to any desired angle relative to the papillary hook 102 to improve visibility while the papillary pointer 102 points to the desired attachment site 114. The physician rotates the leaflet hook 103 by using the grips 104 at the base of the barrel 101. The colors/ projections 109, 109″ of scale 109 match the label colors for corresponding pre-measured loops prostheses with a variety of sizes being made available in a kit. The scale indicator (e.g., a number or color or projection) indicates the size of chordal loops produced by tying suture around the two hooks 102, 103. The physician rotates the barrel 101 so that the leaflet hook 103 is again aligned with the papillary hook 102 (after having been rotated away from papillary hook during measuring) prior to tying loops around projections 102, 103. Thus, the physician can rotate hooks 102, 103 with regard to one another to achieve better site visibility without affecting the measured length. After tying loops around projections 102, 103, the physician pulls the papillary hook 102 back to remove tied loop or loops from the hooks 102, 103. Once the artificial chordae tendineae are in place, a saline test may be performed to verify that the chordal loop size is correct and that the valve is competent.
  • One or more embodiments provide several advantages such as, without limitation: (1) offset of the papillary pointer 202, 203 and the feature that suture is tied around (see, e.g., FIG. 6), (2) rotating leaflet hook (e.g., FIG. 4), (3) color-coded scale (e.g., element 109), (4) using O- rings 108, 109 for friction to stabilize projection deployment and placement, and (5) tying the sutures using posts that are proximal to the papillary pointing element (e.g., FIG. 7). Various embodiments include only a selected one of (1)-(5) while other embodiments include some or all of (1)-(5). Thus, embodiments recognize a previously underappreciated problem regarding the visualization of papillary muscle while retaining a leaflet and provides a solution that provides better visualization while retaining accurate chord length measurement.
  • While scale 109 was indicated as a good way to measure the length of desired cords based on distances between projections 102, 103, in an embodiment a physician may use an image (e.g., echocardiogram) to determine a length and then “dial” in that length using scale 109.
  • Afterwards the loops can be quickly tied using projections 102, 103. In some embodiments, if the physician is using the system 100 to both measure and tie loops, the scale 109 may be unnecessary. However, using scale 109 in such a situation would allow the physician to quickly reset the hooks 102, 103 if for whatever reason the hooks were moved from their proper separation from one another.
  • In an embodiment the hooks 102, 103 rotate in 90 degree intervals whereby one of the hooks “clicks” into place at 90 degree intervals based on notches and spring member systems used to retain a member within a notch until the member is forcibly removed from the notch in order to rotate hooks 102, 103 about each other.
  • Even if there is no permissible rotation of projections 102, 103 with respect to each other, in an embodiment the two projections 102, 103 may be permanently offset with each other (i.e., a line connect the two points is not collinear or parallel to a long axis of the device). In such a situation a third projection may be included such that first projection is located where element 102 is in FIG. 3, a second projection is located where element 103 is located in FIG. 3, and simultaneously a third projection is located where element 103 is located in FIG. 4. In other words, the device may be simplified by removing the rotation element and providing “two static versions” of element 103, one to measure (i.e., the rotated version) and another for tying. In another embodiment, a third projection may be included such that a first projection is located where element 103 is in FIG. 3, a second projection is located where element 102 is located in FIG. 3, and simultaneously a third projection is located where element 102 is located in FIG. 4. In other words, the device may be simplified by removing the rotation element and providing “two static versions” of element 102, one to measure (i.e., the rotated version) and another for tying. The embodiment may provide the two static versions of element 102 are co-planar with each other and one of the two static versions of element 102 and element 103 are co-planar with each other. These two planes may be orthogonal to each other in an embodiment but not necessarily so in other embodiments.
  • An embodiment is used in chordae tendineae repair. However, other embodiments may be used to make measurements in the heart for other procedures. For example, Ventricular Septal Defect (VSD) patches need to be the correct size, and this instrument may be used for such a purpose. Also, tricuspid valve repair and the like are also options.
  • An embodiment includes a cardiovascular surgical apparatus comprising: a sleeve including a distal sleeve end, a proximal sleeve end, and a sleeve long axis (e.g., axis 190 of FIG. 3, which is orthogonal to sleeve short axis 191) extending from the distal sleeve end to the proximal sleeve end.
  • The sleeve may be a conduit but is not so limited and may include, for example only, a member with a channel included therein. For example, a gutter for a house or a bowling alley lane may include a “sleeve” which could function as a channel for rod 115. A “long axis” as used herein is the longest of the main axes for an object and is an imaginary line passing longitudinally through the center of a body.
  • The body further includes a post (e.g., rod) including a distal post end and a proximal post end; a first projection member, coupled to the distal sleeve end, including a first projection member main body (e.g., element 195) and a first projection member retention body (e.g., element 194); and a second projection member coupled to the proximal sleeve end.
  • In the embodiment (a) the first and second projection members (e.g., projections 102, 103) both project outwards and away from the sleeve long axis; (b) the post telescopes distally from within the sleeve and away from the distal sleeve end; (c) at least one of the first and second projection members rotates at least 45 degrees about the sleeve long axis and with respect to another of the first and second projection members; and (d) the first projection member retention body includes a long axis (e.g., axis 193) generally parallel to the sleeve long axis. In an embodiment the first projection member main body includes a long axis (e.g., axis 192) generally orthogonal to the sleeve long axis (e.g., axis 190).
  • In an embodiment at least one of the first and second projection members rotates at least 15, 25, 35, 45, 55, 65, 75, 85, 90, 100, 110, 120, 130, 140, 150, 160, 170, 180 degrees or more about the sleeve long axis and with respect to another of the first and second projection members.
  • While projections 103, 103 include “L” shaped members other projections in other embodiments may not necessarily include “L” shaped members but may instead include a sphere or ball affixed to a post that projects away from axis 190 (orthogonally or otherwise). Projection 102, 103 include portions that project away from axis 190. They may do so at 90 degree angles (see FIG. 3) or otherwise such as 30, 45, 60, 110, 130, 145, 160, 180 degrees and the like. In an embodiment projection 103 may include an “L” member while projection 102 is merely a pointer with which to point at muscle tissue but not necessarily configured to retain or support tissue.
  • While the present invention has been described with respect to a limited number of embodiments, those skilled in the art will appreciate numerous modifications and variations therefrom. It is intended that the appended claims cover all such modifications and variations as fall within the true spirit and scope of this present invention.

Claims (20)

What is claimed is:
1. A cardiovascular surgical apparatus comprising:
a sleeve including a distal sleeve end, a proximal sleeve end, and a sleeve long axis extending from the distal sleeve end to the proximal sleeve end;
a post including a distal post end and a proximal post end;
a first projection member, coupled to the distal sleeve end, including a first projection member main body and a first projection member retention body;
a second projection member coupled to the distal post end;
wherein (a) the first and second projection members both project outwards and away from the sleeve long axis; (b) the post telescopes distally from within the sleeve and away from the distal sleeve end; (c) at least one of the first and second projection members rotates at least 45 degrees about the sleeve long axis and with respect to another of the first and second projection members; and (d) the first projection member retention body includes a long axis generally parallel to the sleeve long axis.
2. The apparatus of claim 1 wherein the first projection member main body includes a long axis generally orthogonal to the sleeve long axis.
3. The apparatus of claim 2 wherein the first projection member retention body couples to the sleeve via the first projection member main body.
4. The apparatus of claim 2 wherein the first projection member main body connects directly and fixedly to the distal sleeve end.
5. The apparatus of claim 1 wherein the sleeve rotates at least 45 degrees with respect to the post.
6. The apparatus of claim 5 wherein the at least one of the first and second projection members rotates at least 45 degrees with respect to the another of the first and second projection members in response to the sleeve rotating at least 45 degrees with respect to the post.
7. The apparatus of claim 1 including a scale having a measurement that changes in response to the post telescoping distally from within the sleeve and the measurement corresponds to a distance between the first and second projection members.
8. The apparatus of claim 1, wherein the second projection member is distal to the first projection member and the first projection member is between the second projection member and the proximal sleeve end.
9. The apparatus of claim 1 wherein the first projection member includes a hooked portion configured to stabilize a valve leaflet.
10. A cardiovascular surgical apparatus comprising:
a sleeve including a distal sleeve end, a proximal sleeve end, and a sleeve long axis extending from the distal sleeve end to the proximal sleeve end;
a post including a distal post end and a proximal post end;
a first projection member coupled to the distal sleeve end;
a second projection member coupled to the distal post end;
wherein (a) the first and second projection members both project outwards and away from the sleeve long axis; (b) the post telescopes distally from within the sleeve and away from the distal sleeve end; and (c) at least one of the first and second projection members rotates at least 45 degrees with respect to another of the first and second projection members.
11. The apparatus of claim 10 wherein the first projection member includes a first projection member main body and a first projection member retention body; the first projection member main body includes a long axis generally orthogonal to the sleeve long axis; and the first projection member retention body includes a long axis generally parallel to the sleeve long axis.
12. The apparatus of claim 11 wherein the first projection member retention body couples to the sleeve via the first projection member main body.
13. The apparatus of claim 10 wherein the first projection member connects directly and fixedly to the distal sleeve end.
14. The apparatus of claim 10 wherein the sleeve rotates at least 45 degrees with respect to the post.
15. The apparatus of claim 10 wherein the at least one of the first and second projection members rotates at least 45 degrees with respect to the another of the first and second projection members in response to the sleeve rotating at least 45 degrees with respect to the post.
16. The apparatus of claim 10 including a scale having a measurement that changes in response to the post telescoping distally from within the sleeve and the measurement corresponds to a distance between the first and second projection members.
17. The apparatus of claim 10, wherein the second projection member is distal to the first projection member and the first projection member is between the second projection member and the proximal sleeve end.
18. The apparatus of claim 10 wherein the first projection member includes a hooked portion configured to stabilize a valve leaflet.
19. A cardiovascular surgical apparatus comprising:
a sleeve including a distal sleeve end, a proximal sleeve end, and a sleeve long axis extending from the distal sleeve end to the proximal sleeve end;
a post including a distal post end and a proximal post end;
a first projection member, coupled to the distal sleeve end, including a first projection member main body and a first projection member retention body;
a second projection member coupled to the distal post end;
a third projection member coupled to the distal post end;
wherein (a) the first, second, and third projection members each project outwards and away from the sleeve long axis; (b) the post telescopes distally from within the sleeve and away from the distal sleeve end; (c) the first projection member retention body includes a long axis generally parallel to the sleeve long axis.
20. The apparatus of claim 19 wherein the second and third projection members are co-planar with each other and the first and second projection members are co-planar with each other.
US14/551,844 2013-11-22 2014-11-24 Chordal sizer Active 2036-05-25 US10052096B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US14/551,844 US10052096B2 (en) 2013-11-22 2014-11-24 Chordal sizer

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361907904P 2013-11-22 2013-11-22
US14/551,844 US10052096B2 (en) 2013-11-22 2014-11-24 Chordal sizer

Publications (2)

Publication Number Publication Date
US20150148692A1 true US20150148692A1 (en) 2015-05-28
US10052096B2 US10052096B2 (en) 2018-08-21

Family

ID=53183220

Family Applications (1)

Application Number Title Priority Date Filing Date
US14/551,844 Active 2036-05-25 US10052096B2 (en) 2013-11-22 2014-11-24 Chordal sizer

Country Status (1)

Country Link
US (1) US10052096B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019145941A1 (en) * 2018-01-26 2019-08-01 Valtech Cardio, Ltd. Techniques for facilitating heart valve tethering and chord replacement

Citations (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5489296A (en) * 1993-12-17 1996-02-06 Autogenics Heart valve measurement tool
US6231601B1 (en) * 1997-05-29 2001-05-15 Edwards Lifesciences Corporation Method of surgery including adjusting the shape of an implement handle
US20030105519A1 (en) * 1997-09-04 2003-06-05 Roland Fasol Artificial chordae replacement
US6598307B2 (en) * 1999-11-17 2003-07-29 Jack W. Love Device and method for assessing the geometry of a heart valve
US20070255396A1 (en) * 2003-06-20 2007-11-01 Medtronic Vascular, Inc. Chrodae Tendinae Girdle
US7431692B2 (en) * 2006-03-09 2008-10-07 Edwards Lifesciences Corporation Apparatus, system, and method for applying and adjusting a tensioning element to a hollow body organ
US20090088837A1 (en) * 2007-09-28 2009-04-02 The Cleveland Clinic Foundation Prosthetic chordae assembly and method of use
US20090281619A1 (en) * 2008-05-09 2009-11-12 Edwards Lifesciences Corporation Low Profile Delivery System for Transcatheter Heart Valve
US20100161041A1 (en) * 2008-12-22 2010-06-24 Valtech Caridio, Ltd. Adjustable repair chords and spool mechanism therefor
US20100249919A1 (en) * 2009-03-31 2010-09-30 The Cleveland Clinic Foundation Pre-sized prosthetic chordae implantation system
US20100312332A1 (en) * 2006-02-27 2010-12-09 Forster David C Methods and Devices for Delivery of Prosthetic Heart Valves and Other Prosthetics
US20120184971A1 (en) * 2010-12-29 2012-07-19 John Zentgraf Exchangeable system for minimally invasive beating heart repair of heart valve leaflets
US20130013056A1 (en) * 2011-07-05 2013-01-10 Chawla Surendra K Valve Repair Instrument
US8449625B2 (en) * 2009-10-27 2013-05-28 Edwards Lifesciences Corporation Methods of measuring heart valve annuluses for valve replacement
US20130178930A1 (en) * 2010-05-20 2013-07-11 Helmut Straubinger Catheter system for introducing an expandable heart valve stent into the body of a patient, insertion system with a catheter system and medical device for treatment of a heart valve defect
US20130231735A1 (en) * 2012-03-01 2013-09-05 Foundry Newco Xii, Inc. Hydraulic delivery systems for prosthetic heart valve devices and associated methods
US20130289717A1 (en) * 2010-03-25 2013-10-31 Synergio Ag Device And A Method For Augmenting Heart Function
US20140114403A1 (en) * 2012-10-19 2014-04-24 St. Jude Medical, Cardiology Division, Inc. Apparatus and method for heart valve repair
US20140135909A1 (en) * 2012-11-14 2014-05-15 Medtronic Vascular Galway Limited Valve Prosthesis Deployment Assembly and Method
US20140142689A1 (en) * 2012-11-21 2014-05-22 Didier De Canniere Device and method of treating heart valve malfunction
US20140155990A1 (en) * 2012-05-30 2014-06-05 Neovasc Inc. Methods and apparatus for loading a prosthesis onto a delivery system

Patent Citations (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5489296A (en) * 1993-12-17 1996-02-06 Autogenics Heart valve measurement tool
US6231601B1 (en) * 1997-05-29 2001-05-15 Edwards Lifesciences Corporation Method of surgery including adjusting the shape of an implement handle
US20030105519A1 (en) * 1997-09-04 2003-06-05 Roland Fasol Artificial chordae replacement
US6598307B2 (en) * 1999-11-17 2003-07-29 Jack W. Love Device and method for assessing the geometry of a heart valve
US20070255396A1 (en) * 2003-06-20 2007-11-01 Medtronic Vascular, Inc. Chrodae Tendinae Girdle
US20100312332A1 (en) * 2006-02-27 2010-12-09 Forster David C Methods and Devices for Delivery of Prosthetic Heart Valves and Other Prosthetics
US7431692B2 (en) * 2006-03-09 2008-10-07 Edwards Lifesciences Corporation Apparatus, system, and method for applying and adjusting a tensioning element to a hollow body organ
US20090088837A1 (en) * 2007-09-28 2009-04-02 The Cleveland Clinic Foundation Prosthetic chordae assembly and method of use
US20090281619A1 (en) * 2008-05-09 2009-11-12 Edwards Lifesciences Corporation Low Profile Delivery System for Transcatheter Heart Valve
US20100161041A1 (en) * 2008-12-22 2010-06-24 Valtech Caridio, Ltd. Adjustable repair chords and spool mechanism therefor
US20100249919A1 (en) * 2009-03-31 2010-09-30 The Cleveland Clinic Foundation Pre-sized prosthetic chordae implantation system
US9480562B2 (en) * 2009-03-31 2016-11-01 The Cleveland Clinic Foundation Pre-sized prosthetic chordae implantation system
US8449625B2 (en) * 2009-10-27 2013-05-28 Edwards Lifesciences Corporation Methods of measuring heart valve annuluses for valve replacement
US20130289717A1 (en) * 2010-03-25 2013-10-31 Synergio Ag Device And A Method For Augmenting Heart Function
US20130178930A1 (en) * 2010-05-20 2013-07-11 Helmut Straubinger Catheter system for introducing an expandable heart valve stent into the body of a patient, insertion system with a catheter system and medical device for treatment of a heart valve defect
US20120184971A1 (en) * 2010-12-29 2012-07-19 John Zentgraf Exchangeable system for minimally invasive beating heart repair of heart valve leaflets
US20130013056A1 (en) * 2011-07-05 2013-01-10 Chawla Surendra K Valve Repair Instrument
US20130231735A1 (en) * 2012-03-01 2013-09-05 Foundry Newco Xii, Inc. Hydraulic delivery systems for prosthetic heart valve devices and associated methods
US20140155990A1 (en) * 2012-05-30 2014-06-05 Neovasc Inc. Methods and apparatus for loading a prosthesis onto a delivery system
US20140114403A1 (en) * 2012-10-19 2014-04-24 St. Jude Medical, Cardiology Division, Inc. Apparatus and method for heart valve repair
US20140135909A1 (en) * 2012-11-14 2014-05-15 Medtronic Vascular Galway Limited Valve Prosthesis Deployment Assembly and Method
US20140142689A1 (en) * 2012-11-21 2014-05-22 Didier De Canniere Device and method of treating heart valve malfunction

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019145941A1 (en) * 2018-01-26 2019-08-01 Valtech Cardio, Ltd. Techniques for facilitating heart valve tethering and chord replacement
EP4248904A3 (en) * 2018-01-26 2023-11-29 Edwards Lifesciences Innovation (Israel) Ltd. Techniques for facilitating heart valve tethering and chord replacement

Also Published As

Publication number Publication date
US10052096B2 (en) 2018-08-21

Similar Documents

Publication Publication Date Title
US20230181319A1 (en) Device that can be implanted in a minimally invasive manner and mitral valve implant system
US11464637B2 (en) Synthetic chord
US20200046498A1 (en) Synthetic chord for cardiac valve repair applications
US11389296B2 (en) Pre-sized prosthetic chordae implantation system
US7842085B2 (en) Annuloplasty ring and holder combination
US8920497B2 (en) Method and instrumentation for acetabular labrum reconstruction
EP1670364B1 (en) Attachment device
US20090192603A1 (en) Adjustable Sizer Devices for Minimally Invasive Cardiac Surgery
US20090088837A1 (en) Prosthetic chordae assembly and method of use
US20140364938A1 (en) Synthetic chord for cardiac valve repair applications
US20060217803A1 (en) Apparatus, system, and method for delivering an annuloplasty ring
CN108135695A (en) A kind of mitral of native configurations
CA2914505A1 (en) Annuloplasty device
US10052096B2 (en) Chordal sizer
US11351029B2 (en) Measurement and simulation device used for aortic valve-sparing root replacement operations
US20170258592A1 (en) Synthetic Chord for Cardiac Valve Repair Applications
US11065110B2 (en) Calcified annulus model for transcatheter aortic valve replacement
Seeburger et al. Gore-Tex loop implantation for mitral valve prolapse: the Leipzig loop technique
WO2020014544A1 (en) Repair device for heart valve repair
ITBO20080384A1 (en) SUBSTITUTE REPLACEMENT DEVICE FOR ATRIO-VENTRICULAR HEART VALVES

Legal Events

Date Code Title Description
AS Assignment

Owner name: ON-X LIFE TECHNOLOGIES, INC., TEXAS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:QUINN, REED;MOULTON, KELLEN;SIGNING DATES FROM 20141121 TO 20141123;REEL/FRAME:034252/0495

AS Assignment

Owner name: HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS AGENT, MARYLAND

Free format text: SECURITY INTEREST;ASSIGNORS:CRYOLIFE, INC., AS GRANTOR;VALVE SPECIAL PURPOSE CO., LLC, AS GRANTOR;ON-X LIFE TECHNOLOGIES, INC., AS GRANTOR;REEL/FRAME:037569/0212

Effective date: 20160120

Owner name: HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS AGENT, MAR

Free format text: SECURITY INTEREST;ASSIGNORS:CRYOLIFE, INC., AS GRANTOR;VALVE SPECIAL PURPOSE CO., LLC, AS GRANTOR;ON-X LIFE TECHNOLOGIES, INC., AS GRANTOR;REEL/FRAME:037569/0212

Effective date: 20160120

AS Assignment

Owner name: ON-X LIFE TECHNOLOGIES, INC., TEXAS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:MEDEMA, RYAN;REEL/FRAME:043541/0895

Effective date: 20170907

FEPP Fee payment procedure

Free format text: ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: BIG.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

AS Assignment

Owner name: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT, NEW YORK

Free format text: PATENT SECURITY AGREEMENT;ASSIGNORS:CRYOLIFE, INC.;ON-X LIFE TECHNOLOGIES, INC. (F/K/A MCRI, INC.);REEL/FRAME:044616/0940

Effective date: 20171201

Owner name: ON-X LIFE TECHNOLOGIES, INC. (F/K/A MCRI, INC.), GEORGIA

Free format text: RELEASE OF SECURITY INTEREST IN PATENTS;ASSIGNOR:HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS ADMINISTRATIVE AGENT;REEL/FRAME:044621/0240

Effective date: 20171201

Owner name: CARDIOGENESIS CORPORATION (N/K/A CRYOLIFE, INC.), GEORGIA

Free format text: RELEASE OF SECURITY INTEREST IN PATENTS;ASSIGNOR:HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS ADMINISTRATIVE AGENT;REEL/FRAME:044621/0240

Effective date: 20171201

Owner name: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AG

Free format text: PATENT SECURITY AGREEMENT;ASSIGNORS:CRYOLIFE, INC.;ON-X LIFE TECHNOLOGIES, INC. (F/K/A MCRI, INC.);REEL/FRAME:044616/0940

Effective date: 20171201

Owner name: CRYOLIFE ACQUISITION CORPORATION, GEORGIA

Free format text: RELEASE OF SECURITY INTEREST IN PATENTS;ASSIGNOR:HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS ADMINISTRATIVE AGENT;REEL/FRAME:044621/0240

Effective date: 20171201

Owner name: ON-X LIFE TECHNOLOGIES, INC. (F/K/A MCRI, INC.), G

Free format text: RELEASE OF SECURITY INTEREST IN PATENTS;ASSIGNOR:HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS ADMINISTRATIVE AGENT;REEL/FRAME:044621/0240

Effective date: 20171201

Owner name: HEMOSPHERE, INC., GEORGIA

Free format text: RELEASE OF SECURITY INTEREST IN PATENTS;ASSIGNOR:HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS ADMINISTRATIVE AGENT;REEL/FRAME:044621/0240

Effective date: 20171201

Owner name: CRYOLIFE, INC., GEORGIA

Free format text: RELEASE OF SECURITY INTEREST IN PATENTS;ASSIGNOR:HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS ADMINISTRATIVE AGENT;REEL/FRAME:044621/0240

Effective date: 20171201

Owner name: VALVE SPECIAL PURPOSE CO., LLC, GEORGIA

Free format text: RELEASE OF SECURITY INTEREST IN PATENTS;ASSIGNOR:HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS ADMINISTRATIVE AGENT;REEL/FRAME:044621/0240

Effective date: 20171201

Owner name: CARDIOGENESIS CORPORATION (N/K/A CRYOLIFE, INC.),

Free format text: RELEASE OF SECURITY INTEREST IN PATENTS;ASSIGNOR:HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS ADMINISTRATIVE AGENT;REEL/FRAME:044621/0240

Effective date: 20171201

STCF Information on status: patent grant

Free format text: PATENTED CASE

CC Certificate of correction
MAFP Maintenance fee payment

Free format text: PAYMENT OF MAINTENANCE FEE, 4TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1551); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

Year of fee payment: 4

AS Assignment

Owner name: ARES CAPITAL CORPORATION, NEW YORK

Free format text: SECURITY INTEREST;ASSIGNOR:ON-X LIFE TECHNOLOGIES, INC.;REEL/FRAME:066160/0237

Effective date: 20240118

AS Assignment

Owner name: ON-X LIFE TECHNOLOGIES, INC., TEXAS

Free format text: TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS;ASSIGNOR:DEUTSCHE BANK AG NEW YORK BRANCH;REEL/FRAME:066360/0562

Effective date: 20240118

Owner name: CRYOLIFE, INC., GEORGIA

Free format text: TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS;ASSIGNOR:DEUTSCHE BANK AG NEW YORK BRANCH;REEL/FRAME:066360/0562

Effective date: 20240118